Home › Myasthenia Gravis › Illinois › Chicago
Myasthenia Gravis clinical trials in Chicago, IL
4 studies for Myasthenia Gravis are looking for participants at sites in and around Chicago (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Inebilizumab in Children With Generalized Myasthenia Gravis (gMG)
RecruitingPhase 2
- Ann and Robert H Lurie Childrens Hospital of Chicago, Chicago
RESET-MG: A Study to Evaluate the Safety and Efficacy of CABA-201 in Participants With Generalized Myasthenia Gravis
RecruitingPhase 1/2
- Northwestern Memorial Hospital, Chicago
Study of Aritinercept in Patients With Generalized Myasthenia Gravis
RecruitingPhase 1/2
- Aurinia Investigational Site, Chicago
A Study to Investigate OCS Tapering in Adult Participants With Generalized Myasthenia Gravis Treated With Ravulizumab
RecruitingPhase 4
- Research Site, Chicago
About Myasthenia Gravis
Myasthenia gravis (MG) is an autoimmune disease that weakens the muscles under your control. Find out about MG causes, symptoms, and treatment.
More about Myasthenia Gravis on MedlinePlus
Myasthenia Gravis trials in other cities
- Tampa, FL11 studies
- Houston, TX10 studies
- Durham, NC8 studies
- Columbus, OH8 studies
- Boca Raton, FL8 studies
- Milwaukee, WI7 studies
- Washington, DC6 studies
- Detroit, MI6 studies
- Miami, FL6 studies
- New York City, NY6 studies
- Philadelphia, PA6 studies
- Portland, OR6 studies
Other studies in Chicago
- Breast Cancer59 studies
- Non-Small Cell Lung Cancer59 studies
- Cancer (all types)51 studies
- Prostate Cancer45 studies
- Lung Cancer43 studies
- Metastatic Cancer42 studies
- Obesity40 studies
- Ovarian Cancer36 studies
- Colorectal Cancer32 studies
- Stroke31 studies
- Head and Neck Squamous Cell Carcinoma29 studies
- Overweight29 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.